Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
89bio, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ETNB
Nasdaq
2836
www.89bio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for 89bio, Inc.
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Jun 6th, 2025 2:05 pm
89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
- Jun 4th, 2025 2:05 pm
Why 89bio, Inc. (ETNB) Is Among the Best Low Priced Biotech Stocks to Buy Now
- May 13th, 2025 6:46 am
89bio to Participate in Upcoming Investor Conferences
- May 6th, 2025 2:05 pm
89bio Reports First Quarter 2025 Financial Results and Corporate Updates
- May 1st, 2025 2:05 pm
Citi says SMid biotechs alternative to large caps as it starts coverage
- Mar 13th, 2025 9:34 am
Bears are Losing Control Over 89BIO (ETNB), Here's Why It's a 'Buy' Now
- Mar 12th, 2025 7:55 am
89bio to Participate in the Leerink Partners Global Healthcare Conference
- Mar 3rd, 2025 2:05 pm
89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
- Feb 27th, 2025 2:05 pm
Wall Street Analysts See a 171.42% Upside in 89BIO (ETNB): Can the Stock Really Move This High?
- Feb 20th, 2025 7:55 am
Should You Buy 89BIO (ETNB) After Golden Cross?
- Feb 20th, 2025 7:55 am
Institutional investors have a lot riding on 89bio, Inc. (NASDAQ:ETNB) with 58% ownership
- Feb 6th, 2025 4:45 am
89bio Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Feb 3rd, 2025 6:00 am
89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants
- Jan 28th, 2025 8:31 pm
Why 89bio Stock Lagged the Market Today
- Jan 28th, 2025 2:59 pm
Akero Therapeutics Stock Nearly Doubles — Pulling 89bio Higher — On Positive MASH Study
- Jan 27th, 2025 2:24 pm
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
- Jan 27th, 2025 2:12 pm
89bio Provides Business Update and Outlook for 2025
- Jan 13th, 2025 6:00 am
New Strong Sell Stocks for January 7th
- Jan 7th, 2025 1:17 am
Why Is 89bio, Inc. (ETNB) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?
- Dec 4th, 2024 11:02 am
Scroll